Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
1 raison identifiée
Praticien-chercheur
15 articles scientifiques publiés — formation continue solide
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
11
11 articles ont été cités au moins 11fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
h-index
Total citations reçues
837
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
30
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
11
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
François Jacob : oser la pensée, oser l’action
2015CongrèsHommage à François Jacob - Co - organisé par l’Institut Pasteur et l’Académie des Sciences
François Jacob: daring thought, daring action
2015CongrèsTribute to François Jacob - January 27, 2015.
François Jacob, or the thirst for novelty
2014ArticleResearch in Microbiology
Preparation and Delivery of 4-Hydroxy-Tamoxifen for Clonal and Polyclonal Labeling of Cells of the Surface Ectoderm, Skin, and Hair Follicle
2013Chapitre
Elongation in chordates: a view from clonal analysis
2010Congrès22nd PASTEUR - WEIZMANN SYMPOSIUM “Stem Cells – From Basic Biology to Translational Medicine" and Joint Meeting of the French and Japanese Societies for Developmental Biology “From Cells to Organs”
Hair follicle renewal: authentic morphogenesis that depends on a complex progression of stem cell lineages
2010ArticleDevelopment (Cambridge, England)
Clonal origin of the mammalian forebrain from widespread oriented mixing of early regionalized neuroepithelium precursors
2006ArticleDevelopmental Biology
Hair follicle renewal: organization of stem cells in the matrix and the role of stereotyped lineages and behaviors
2005ArticleDevelopment (Cambridge, England)
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
The Journal of bone and joint surgery. British volume · 2004
The results of conventional hip replacement in young patients with osteoarthritis have not been encouraging even with improvements in the techniques of fixation and in the bearing surfaces. Modern metal-on-metal hip resurfacing was introduced as a less invasive method of joint reconstruction for this particular group. This is a series of 446 hip resurfacings (384 patients) performed by one of the authors (DJWM) using cemented femoral components and hydroxyapatite-coated uncemented acetabular components with a maximum follow-up of 8.2 years (mean 3.3). Their survival rate, Oxford hip scores and activity levels are reviewed. Six patients died due to unrelated causes. There was one revision (0.02%) out of 440 hips. The mean Oxford score of the surviving 439 hips is 13.5. None of the patients were told to change their activities at work or leisure; 31% of the men with unilateral resurfacings and 28% with bilateral resurfacings were involved in jobs that they considered heavy or moderately heavy; 92% of men with unilateral hip resurfacings and 87% of the whole group participate in leisure-time sporting activity. The extremely low rate of failure in spite of the resumption of high level occupational and leisure activities provides early evidence of the suitability of this procedure for young and active patients with arthritis.
BMJ (Clinical research ed.) · 2012
The bone & joint journal · 2014
We report a 12- to 15-year implant survival assessment of a prospective single-surgeon series of Birmingham Hip Resurfacings (BHRs). The earliest 1000 consecutive BHRs including 288 women (335 hips) and 598 men (665 hips) of all ages and diagnoses with no exclusions were prospectively followed-up with postal questionnaires, of whom the first 402 BHRs (350 patients) also had clinical and radiological review. Mean follow-up was 13.7 years (12.3 to 15.3). In total, 59 patients (68 hips) died 0.7 to 12.6 years following surgery from unrelated causes. There were 38 revisions, 0.1 to 13.9 years (median 8.7) following operation, including 17 femoral failures (1.7%) and seven each of infections, soft-tissue reactions and other causes. With revision for any reason as the end-point Kaplan–Meier survival analysis showed 97.4% (95% confidence interval (CI) 96.9 to 97.9) and 95.8% (95% CI 95.1 to 96.5) survival at ten and 15 years, respectively. Radiological assessment showed 11 (3.5%) femoral and 13 (4.1%) acetabular radiolucencies which were not deemed failures and one radiological femoral failure (0.3%). Our study shows that the performance of the BHR continues to be good at 12- to 15-year follow-up. Men have better implant survival (98.0%; 95% CI 97.4 to 98.6) at 15 years than women (91.5%; 95% CI 89.8 to 93.2), and women < 60 years (90.5%; 95% CI 88.3 to 92.7) fare worse than others. Hip dysplasia and osteonecrosis are risk factors for failure. Patients under 50 years with osteoarthritis fare best (99.4%; 95% CI 98.8 to 100 survival at 15 years), with no failures in men in this group. Cite this article: Bone Joint J 2014;96-B:1298–1306.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Foot & ankle specialist · 2026 · Journal Article
Amponsah NF, Baidya J, Pignataro J, Mody K, et al.
Current research in microbial sciences · 2026 · Journal Article
Moreira de Gouveia MI, Blanchot A, Garrivier A, Daniel J, et al.
Foot & ankle specialist · 2025 · Journal Article
Lencer AJ, Miller M, McCahon J, Kohring A, et al.
Bone & joint research · 2019 · Journal Article
Treacy RBC, Holland JP, Daniel J, Ziaee H, et al.
Foot & ankle international · 2019 · Journal Article
Sidon E, Rogero R, Bell T, McDonald E, et al.
Cardiovascular research · 2015 · Journal Article
Dutzmann J, Daniel JM, Bauersachs J, Hilfiker-Kleiner D, et al.
The bone & joint journal · 2014 · Journal Article
Daniel J, Pradhan C, Ziaee H, Pynsent PB, et al.
The Journal of bone and joint surgery. British volume · 2008 · Evaluation Study
McMinn DJ, Daniel J, Ziaee H, Pradhan C
The Journal of bone and joint surgery. British volume · 2004 · Journal Article
Daniel J, Pynsent PB, McMinn DJ
British medical journal · 1969 · Journal Article
Brewerton DA, Daniel JW
Foot & ankle specialist · 2021 · Journal Article
Tsai J, Daniel JN, McDonald EL, Pedowitz DI, et al.
BMJ (Clinical research ed.) · 2012 · Letter
McMinn DJ, Daniel J, Treacy RB, Riley RD
BMJ (Clinical research ed.) · 2012 · Journal Article
McMinn DJ, Snell KI, Daniel J, Treacy RB, et al.
Pennsylvania medicine · 1969 · Journal Article
Daniel JW
Foot & ankle specialist · 2023 · Meta-Analysis
Mousavian A, Baradaran A, Schon LC, Daniel J, et al.
Foot & ankle specialist · 2023 · Meta-Analysis
Mousavian A, Baradaran A, Schon LC, Daniel J, et al.